Lupa Kata Sandi? Klik di Sini

atau Masuk melalui

Belum Memiliki Akun Daftar di Sini


atau Daftar melalui

Sudah Memiliki Akun Masuk di Sini

Konfirmasi Email

Kami telah mengirimkan link aktivasi melalui email ke rudihamdani@gmail.com.

Klik link aktivasi dan dapatkan akses membaca 2 artikel gratis non Laput di koran dan Majalah Tempo

Jika Anda tidak menerima email,
Kirimkan Lagi Sekarang

Kimia Farma Producing, Distributing Three Therapeutic COVID-19 Drugs

Translator

Antara

8 July 2021 10:24 WIB

Kimia Farma logo

TEMPO.CO, Jakarta - State-owned pharmaceutical company PT Kimia Farma has said it is producing and distributing three variants of therapeutic COVID-19 drugs azithromycin, favipiravir, and remdesivir.

"Kimia Farma is producing azithromycin tablets, which are being produced by a total of 33 companies in Indonesia, with 19 of the companies producing generic azithromycin, including Kimia Farma," said chairman of PT Kimia Farma, Verdi Budidarmo, at a meeting with Commission VI of the House of Representatives, accessed virtually from Jakarta on Wednesday.

The company has distributed at least 58 thousand boxes of azithromycin since June 2021, with each box containing 20 tablets, he disclosed.

"This month, we will distribute nearly six million tablets and in the following months," he added.

Providing details on the distribution chain of the drug, he said a total of 1,233 PT Kimia Farma pharmacies located in different areas are among those stocking the drug currently.

PT Kimia Farma is also producing favipiravir and the company is expecting to boost production to seven million tablets by July 23, 2021, Budidarmo informed.

He said the drug has been cleared for emergency use by the Food and Drug Supervisory Agency (BPOM) and has been distributed to several hospitals through the company's trading and distribution channel.

"Favipirapir is being produced by Kimia Farma. There are six domestic industries that are also producing it using almost all imported materials," he added.

The state-owned pharmaceutical company is also aiming to meet the public demand for the therapeutic drug remdesivir, Budidarmo said.

"There are currently seven pharmaceutical industries in Indonesia that are importing the drug, one of which is Kimia Farma," he said.

Domestic demand for remdesivir injections, he continued, is hoped to be fulfilled by September this year.

PT Kimia Farma is involved in the domestic development of remdesivir injections, along with PT Phapros, Budidarmo informed adding, the raw medicinal materials for the injections will be produced by a subsidiary of his company.

Read also: Kimia Farma Preps 7.5 Mn Doses of Sinopharm for Private Vaccination Program

ANTARA



Indonesia's Aviation Sector to Recover 100% in 2024 Post COVID-19 Pandemic

20 hari lalu

Indonesia's Aviation Sector to Recover 100% in 2024 Post COVID-19 Pandemic

The recovery in the aviation sector post-COVID-19 pandemic has reached 83 percent.


How India's COVID Lockdowns Impacted Menstrual Health

33 hari lalu

How India's COVID Lockdowns Impacted Menstrual Health

Limited access to period products during India's COVID lockdown highlighted how far public health initiatives have to go when it comes to menstruation


How Do You Eliminate or Eradicate an Infectious Disease?

33 hari lalu

How Do You Eliminate or Eradicate an Infectious Disease?

The COVID-19 pandemic gave the world a crash course in epidemiology and showed in real time how an infectious disease can spread or be contained.


Why Have Efforts to Eradicate TB Been So Slow?

36 hari lalu

Why Have Efforts to Eradicate TB Been So Slow?

Tuberculosis (TB) is one of the world's most deadly infectious diseases - but the COVID-19 pandemic dramatically slowed efforts to eliminate it.


Depok Records 200% Hike in COvid-19 Cases Last December

3 Januari 2024

Depok Records 200% Hike in COvid-19 Cases Last December

Depok Mayor Mohammad Idris revealed that the number of Covid-19 cases in the city surged from 100 to 300 as of December 2023


Indonesia Still Provides Free COVID-19 Vaccines for 2 Vulnerable Groups

2 Januari 2024

Indonesia Still Provides Free COVID-19 Vaccines for 2 Vulnerable Groups

Indonesia's Health Ministry has announced that COVID-19 vaccines would remain free of charge for two vulnerable groups starting from January 1, 2024.


Self-paid COVID-19 Vaccination Program to Start in 2024

28 Desember 2023

Self-paid COVID-19 Vaccination Program to Start in 2024

The Jakarta Health Agency is set to begin implementing the self-paid COVID-19 vaccination starting January 1, 2024.


Jakarta to Celebrate New Year's Eve with 'Malam Muda Mudi'

27 Desember 2023

Jakarta to Celebrate New Year's Eve with 'Malam Muda Mudi'

The Jakarta provincial government is set to hold Malam Muda Mudi, or the Night of the Youths, to enliven the 2024 New Year's Eve celebrations.


Indonesia Sees Rising Cases of Covid-19 Ahead of Year-end

26 Desember 2023

Indonesia Sees Rising Cases of Covid-19 Ahead of Year-end

Nearing the end of 2023, the Health Ministry recorded that the spread of Covid-19 variant JN.1 in Indonesia continues to increase, reaching 41 cases.


Indonesia's Health Ministry Reports Deaths of Two Omicron JN.1 Patients in Batam

26 Desember 2023

Indonesia's Health Ministry Reports Deaths of Two Omicron JN.1 Patients in Batam

The Indonesian Ministry of Health reports the death of two patients infected with the Omicron JN.1 and XBB.2.3.10.1 (GE.1) sub-variants of Covid-19.